Blog
-
Colman Domingo to play Cowardly Lion in upcoming Wicked sequel
American actor and playwright Colman Domingo has been cast as the Cowardly Lion in the upcoming Wicked: For Good film, putting to rest a weekend of internet speculation on who would play the role.
The announcement was made by the film’s official…
Continue Reading
-
Last Rites Director on Missed Taissa Farmiga Cameo
[This story contains spoilers for The Conjuring: Last Rites.]
Billed as the “fourth-and-final” film in The Conjuring series, Last Rites has grossed a franchise record of nearly $500 million at the worldwide box office. That puts…
Continue Reading
-
I Moved From London to Singapore, but Only Lasted 18 Months
In April 2019, I was ambitious, burnt out, and heartbroken, so I took on a temporary assignment in Singapore with my employer, a large tech-based retailer. In the first few weeks, I was pleasantly distracted by the…
Continue Reading
-
Taiwan: More local dengue reported
The Taiwan Centers for Disease Control (CDC) announced today that there were three new local dengue fever cases (two in Tainan City’s South District and one in Taoyuan City’s Taoyuan District).
The cases, were two men and one woman, aged…
Continue Reading
-
MikeCheck: Evaluating every Grizzlies’ roster spot amid countdown to season opener – NBA
- MikeCheck: Evaluating every Grizzlies’ roster spot amid countdown to season opener NBA
- “Can’t Bank on Ja Morant Being Healthy”: Evan Turner Doesn’t Believe the Grizzlies ‘Want to Win’ This Year The SportsRush
- Herrington: Grizzlies…
Continue Reading
-
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
In the 5 years since the start of the COVID-19 pandemic, post-COVID-19 sequelae, also known as long COVID, has grown in notoriety and concern. Concurrently, the landscape of research, possible treatments, and patient support has become…
Continue Reading
-
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O’Shea, MD, MSc | NeurologyLive
“In Huntington disease, we want to track the neuropathological and the clinical progression, and we want to make sure these are sensitive to potential disease-modifying treatments, which I’ll talk about in a little bit. The most commonly used…
Continue Reading
-
Can SpaceX Help NASA Return to the Moon by 2027?
With a target of heading back to the moon by mid-2027, NASA is betting big on its multibillion-dollar public-private partnership with SpaceX, the Texas-based rocketmaker helmed by technology billionaire Elon Musk.
However, technical…
Continue Reading
-
Survey on Assessment of Health and Environmental Hazards and Risks of Surface-Treated Nanomaterials Will Close October 31, 2025
The European Union (EU) Observatory for Nanomaterials (EUON) has contracted the Nanotechnology Industries Association (NIA) and Yordas Group to undertake a study on the assessment of health and environmental hazards and risks of surface-treated nanomaterials. The aim of the study is to review and collect scientific information and data on how surface treatment can affect the properties of nanomaterials and potentially have an impact of their fate and potential risks. The study includes a market survey to understand:
- Which surface-treated nanomaterials can be found on the EU market and in which quantities; and
- The industrial sectors or fields of application in which these surface-treated nanomaterials are being used.
To supplement other data gathering and help qualify data found using different sources, the survey seeks to gather people’s direct knowledge of this field. The survey is open to anyone with knowledge of the manufacturer or use of surface-treated nanomaterials within the EU. This may include manufacturers or suppliers of surface-treated nanomaterials, end users of surface-treated nanomaterials, researchers aware of surface-treated nanomaterials, or laboratories, service providers, or research and training organizations with knowledge of surface-treated nanomaterials. The survey will close October 31, 2025. Bergeson & Campbell, P.C. is a proud member of the NIA.
Continue Reading
